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Translocase mediates the transport of preproteins
across the inner membrane of Escherichia coli. SecA
binds with high affinity to the membrane-embedded
protein-conducting SecYEG complex and serves as both
a receptor for secretory proteins and as an ATP-driven
molecular motor. Cycles of ATP binding and hydrolysis
by SecA drive the progressive movement of the prepro-
tein across the membrane. Surface plasmon resonance
allows an online monitoring of protein interactions.
Here we report on the kinetic analysis of the interaction
between SecA and the membrane-embedded SecYEG
complex. Immobilization of membrane vesicles contain-
ing overproduced SecYEG on the Biacore Pioneer L1
chip allows the detection of high affinity SecA binding
to the SecYEG complex and online monitoring of the
translocation of the secretory protein proOmpA. SecA
binds tightly to the SecYEGproOmpA complex and is
released only upon ATP hydrolysis. The results provide
direct evidence for a model in which SecA cycles at the
SecYEG complex during translocation.
SecA (1) is the central component of the translocase, a mul-
timeric enzyme complex that mediates the translocation of
secretory proteins (preproteins) across the inner membrane of
Escherichia coli (reviewed in Ref. 2). SecA is a large (102 kDa)
homodimeric protein (3, 4) that localizes in the cytosol and
associates peripherally with the inner membrane. At the mem-
brane, SecA functions as a preprotein receptor and as an ATP-
driven molecular motor that threads the preprotein through a
pore formed by an oligomeric assembly of the integral SecYEG
membrane protein complex (5–8). SecA binds the SecYEG com-
plex with high affinity. This interaction occurs at least via
direct association with SecY (9). SecG is not required for high
affinity SecA binding (10), but cross-linking studies indicate
that both proteins interact physically during the SecA reaction
cycle (11). In addition, SecA associates with low affinity with
phospholipids (12).
SecA contains two nucleotide binding domains (NBDs)1 that
are both indispensable for protein translocation (13, 14). NBD1
is a high affinity catalytic NBD (KD ADP  0.15 M) located
near the N terminus of the protein. This domain shares signif-
icant structural similarity with the DEAD motor domains of
helicases (15). The more distally located NBD2 may have a
regulatory function instead of being a true ATP hydrolytic site
(16, 17). The events that take place during ATP-driven protein
translocation have been partially resolved. SecYEG-bound
SecA binds preproteins via direct recognition of the signal
sequence and mature domain (12, 18). Translocation of the
preprotein is driven by multiple cycles of ATP binding and
hydrolysis at SecA (19, 20). Each catalytic cycle of SecA in-
volves two distinct translocation steps that utilize the energy of
either preprotein or ATP binding to allow the translocation of
the preprotein in 20- to 30-amino acid steps (19). Although
several studies have addressed the order of events during pro-
tein translocation, relatively little is known about the SecA-
SecYEG interaction in this process. SecA has been proposed to
partition between the cytoplasm and the inner membrane dur-
ing its reaction cycle (19, 21), but other studies question the
SecA membrane cycling model as a significant fraction of active
SecA remains stably associated with the membrane throughout
the translocation reaction (22). Indirect evidence, using SecA
bound to a liposome surface instead to SecYEG, suggests that
ATP hydrolysis drives the release of the SecA-bound preprotein
(19). To address the SecA cycling model directly, we have stud-
ied the SecA-SecYEG interaction by surface plasmon resonance
(SPR). SPR is a versatile technique that allows rapid, online
monitoring of protein interactions. We have used the Biacore
Pioneer L1 chip to immobilize inner membrane vesicles (IMVs)
containing wild-type and overproduced levels of SecYEG. The
immobilized vesicles bind SecA with high affinity in a SecYEG-
dependent manner and could be used to monitor protein
translocation online. The data demonstrate that SecA binds
tightly to the SecYEG complex when it contains a trapped
preprotein translocation intermediate. Dissociation from the
SecYEGpreprotein complex requires ATP hydrolysis. The re-
sults provide direct evidence for a translocation model in which
SecA can cycle between a soluble and SecYEG-associated state
in an ATP-dependent manner.
EXPERIMENTAL PROCEDURES
Materials—E. coli SecA (1), SecB (23), proOmpA (24), and Cys-less
proOmpA (25) were purified as described. IMVs containing wild-type
levels of SecYEG, overexpressed His-tagged SecYEG, or overexpressed
His-tagged SecYE were obtained from E. coli SF100 cells transformed
with pET302 (26), pET610 (27), or pET320 (28) as described (27). ADP,
ATP, AMP-PNP, and bovine serum albumin were from Sigma.
SPR—SPR measurements were performed using a two-channel
BIAlite SPR system (Biacore AB, Uppsala, Sweden). IMVs (2 mg/ml in
Buffer A (50 mM Tris-HCl, pH 8.0, 50 mM KCl, 5 mM MgCl2, 1 mM
dithiothreitol) were passed 11 times through a 100-nm polycarbonate
membrane (Avestin, Ottawa, Ontario, Canada) and immobilized on a
Pioneer L1 sensor chip (Biacore AB, Uppsala, Sweden). Binding exper-
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iments were performed in Buffer A with 0.5 mg/ml bovine serum albu-
min and 150 mM KCl at 25 or 30 °C. Stability of the baseline and
regeneration of SecA binding sites were obtained by injection of 100 mM
Na2CO3, pH 10.
Data Analysis—The SPR response prior to injection and the time of
injection were adjusted to zero. Binding curves were corrected for
changes in the refractive index of the buffer and nonspecific binding to
IMVs and the chips surface by the BiacoreX control software 2.0.1
(Biacore AB, Uppsala, Sweden). Corrected binding curves of SecA as-
sociation and dissociation were quantitatively analyzed using the
BIAevalution 2.2.4 software (Biacore AB, Uppsala, Sweden). The data
were fitted to a pseudo-first order model of simple 1:1 binding (A  B7
AB) by non-linear regression. The dissociation rate constant was de-
rived from the equation Rt  R0e
koff(tt0) where Rt is the response in
response units (RU) at time t, R0 is the response at t0, and koff is the
dissociation rate constant. The association rate constant kon was de-
rived from the equation Rt  Req(1  e
(kon[C]koff)(tt0), where [C] is the
ligand concentration, and Req is the steady state response level. In
addition, the dissociation phase was fitted to a parallel dissociation
model (AB1  AB2 7 A  B1  B2), using the equation Rt 
R1e
koff1(tt0)  (R0  R1)e
koff2(tt0). The affinity (KD) was calculated
from the ratio koff/kon and from the response levels attained at equilib-
rium for different SecA concentrations by Scatchard analysis.
Other Biochemical Techniques—Protein concentrations were deter-
mined using the Bio-Rad DC protein assay with bovine serum albumin
as a standard.
RESULTS
Detection of SecA-SecYEG Interaction by Surface Plasmon
Resonance—To study the interaction between SecA and the
SecYEG complex, IMVs containing overexpressed SecYEG
(SecYEG) were immobilized on a Pioneer L1 sensor chip. The
surface of this sensor chip consists of dextran modified with
lipophilic anchoring molecules that protrude the lipid bilayer
thereby immobilizing the vesicles. The Bialite SPR system
contains two flow cells that enable simultaneous monitoring of
a sample and a control. A control surface was prepared by
loading IMVs containing wild-type (WT) levels of SecYEG onto
the second cell. IMV immobilization caused an SPR response
between 2500 and 4500 RU (data not shown). Loading levels of
the control (WT) and sample (SecYEG) cells were similar to
allow direct comparison.
The binding of SecA to the immobilized IMVs was followed in
time (Fig. 1A). The responses of the WT and SecYEG IMVs in
Fig. 1A include a “bulk” contribution to the SPR signal, i.e. a
change in the signal because of changes in the refractive index
of the injection buffer. After bulk correction, the SecYEG
response was increased five times compared with the WT re-
sponse, demonstrating specific SecA-SecYEG interaction. Spe-
cific binding of SecA to SecYEG reached saturation of available
binding sites at a SecA concentration of about 48 nM (data not
shown). The association and dissociation rates of the SecA-
SecYEG interaction were determined after correction of the
SecYEG IMV response for the WT IMVs response, which
includes the bulk contribution and nonspecific SecA binding
(see Fig. 1A and Table I). The association of SecA with the
SecYEG complex fitted best to a pseudo-first order model of
simple 1:1 binding (A B7 AB), with a kon of 2.5 0.4 10
6
M1s1 (see Fig. 1B and Table I). The dissociation phase was
more accurately described by a parallel dissociation model
(AB1  AB2 7 A  B1  B2) with a koff1 of 2.8  0.4  10
2
s1 (27%) and a koff2 of 3.9  0.4  10
3 s1 (73%) (see Fig. 1C
and Table I). Parallel dissociation can be caused by the pres-
ence of two ligand binding sites with different affinities. How-
ever, this phenomenon has been reported to occur frequently in
SPR experiments and can also be attributed to sterical hin-
drance (molecular crowding), mass transport limitations, or
non-uniform immobilization of the binding sites (29). The koff1
of the parallel dissociation model yielded an unrealistic (nega-
tive) kon; therefore, the parallel character of the dissociation
phase probably does not reflect the existence of two different
SecA binding sites. The affinity (KD) determined by the ratio
koff/kon (Table I) was comparable with the SecA binding affinity
reported in previous studies (30–32). The kinetic parameters
for SecA binding kinetics were independent of SecA concentra-
tion (3–96 nM), and an increased flow rate from 20 to 40 l/min
yielded comparable response curves, indicating that the kinet-
ics were not influenced by mass transport limitations. To val-
idate the kinetic analysis of the SecA-SecYEG interaction, the
FIG. 1. Specific SecA-SecYEG interaction visualized by SPR. A,
SPR sensogram of the binding of SecA (48 nM) to a Pioneer L1 sensor
chip covered with IMVs containing wild-type (dotted line) or overex-
pression levels of SecYEG (dashed line). The solid line indicates the
corrected, specific SecA binding. The arrowheads on the x and y axes
indicate the end of the injection and the contribution of the bulk flow,
respectively. Binding experiments were performed at a flow rate of 20
l/min at 25 °C. A small fraction of SecA was slowly released. B, fit of
the association phase of specific SecA binding to IMVs containing over-
expressed SecYEG. The data (gray lines) were fitted (black lines) to a
model assuming homogeneous single-site interaction (A  B 7 AB) or
a model assuming parallel interaction (A  B1  B27 AB1  AB2). C,
fit of the dissociation phase of specific SecA binding to IMVs containing
overexpressed SecYEG. Data (gray lines) were fitted (black lines) to a
model assuming homogeneous single-site or parallel interaction.
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results were subjected to the self-consistency tests proposed
by Schuck and Minton (33). The KD determined by Scatchard
analysis (3.6  0.2 nM for SecYEG) from the response levels
attained at equilibrium for different SecA concentrations was
comparable with the koff/kon ratio. The koff calculated using
linear regression of the dependence of kobs on [C] (kobs 
kon[C]  koff, where [C] is the SecA concentration) was approx-
imately equal to koff determined by fitting to Rt  R0e
koff(t  t0)
and the kobs  koff for all SecA concentrations tested (data not
shown). SPR experiments with immobilized vesicles containing
SecYE instead or SecYEG (Table I) yielded identical results.
This confirms a previous study (10) in which SecG was shown
not to contribute to the high affinity binding of SecA to the
SecYE complex. Taken together, these data demonstrate that
SPR can be used to directly monitor the kinetics of the high
affinity interaction between SecA and the SecYEG complex.
Binding of proOmpA to the SecASecYEG Complex—Se-
cYEG-bound SecA binds preproteins either in a complex with
the chaperone SecB or as free preprotein, but the exact affinity
of the interaction of SecA with preproteins is not known (34).
To characterize the interaction of the preprotein proOmpA with
SecYEG-bound SecA in more detail by SPR, IMVs were immo-
bilized as described above and saturated with SecA. Subse-
quently, proOmpA was injected in either the presence or ab-
sence of SecB. In the absence of SecB, proOmpA binding
resulted in a response of 60 RU (Fig. 2, dashed line) and
occurred with an affinity of 14  1 nM (Table II). In the pres-
ence of SecB the binding response increased to 120 RU (Fig. 2,
solid line). This increased response is probably because of the
binding of the larger proOmpASecB complex, because binding
of SecB alone could not be detected under the conditions ap-
plied (Fig. 2, dotted line). Biochemical analysis demonstrated
that the SecB was normally active (data not shown). The
proOmpASecB complex bound to the SecASecYEG complex
with an affinity of 16  2 nM (Table II), which is nearly iden-
tical to the affinity of proOmpA binding in the absence of SecB.
Protein Translocation Monitored by SPR—To determine
whether SPR can be used to monitor the interactions that occur
during the protein translocation cycle, experiments were con-
ducted in the presence of ATP. Injection of SecA, proOmpA, and
SecB resulted in an SPR response of 200 RU (Fig. 3A, dashed
line), which corresponds largely to the sum of the individual
binding steps of SecA (100 RU; see Fig. 1) and the
proOmpASecB complex (120 RU; see Fig. 2). When ATP was
included in the injection buffer, a significant increase in the
SPR response was observed that did not reach saturation at the
end of the association phase (Fig. 3A, solid line). To address
the possibility that the increased SPR response with time was
caused by translocation of injected proOmpA, an experiment
was conducted that allowed for only one round of translocation.
Oxidation of proOmpA induces the formation of an internal
disulfide bridge between Cys290 and Cys302, which causes a
translocation arrest in the absence of the proton motive force
(19, 35). As a consequence, translocated proOmpA accumulates
as a translocation intermediate (I29) that occupies the translo-
cation site and blocks it for a second round of translocation (7,
19, 35). The alkaline carbonate treatment after the immobili-
zation of the vesicles removes the F1 domain of the F0F1-
ATPase and thus the ability to generate a proton motive force
upon the addition of ATP (data not shown). When SecA,
proOmpASecB, and ATP were injected under oxidizing condi-
tions, the SPR signal saturated quickly and reached a much
lower level than under reducing conditions (Fig. 3B). The max-
imal response for the injection of SecA, ATP, and oxidized
proOmpASecB (200 RU; see Fig. 3B, solid line) was compa-
rable with the response of an injection of SecA and
proOmpASecB without nucleotides (Fig. 3B, dotted line). This
is consistent with the observation that oxidized proOmpA
blocks the translocation sites for further translocation (7, 19,
35). Oxidation of a Cys-less proOmpA mutant yielded a re-
sponse similar to wild-type proOmpA under reducing condi-
tions (data not shown). After reduction of the disulfide bond
with dithiothreitol, addition of SecA, proOmpASecB, and ATP
resulted in a further increase in the SRP response consistent
with a new cycle of translocation (data not shown). These
results demonstrate that the immobilized vesicles are capable
of translocation and that SPR can be used to monitor protein-
protein interactions during translocation.
Release of SecA from a SecYEG-trapped Preprotein Is ATP-
dependent and Does Not Require Completion of Transloca-
tion—In the absence of ATP, binding of SecA and
proOmpASecB was reversible, and dissociation occurred im-
mediately at the end of the injection (Fig. 3A, dashed line). In
contrast, when the complex was formed under translocation
conditions (i.e. with ATP), it remained stably associated with
the membrane (Fig. 3A, solid line) and was even resistant
against alkaline carbonate treatment (data not shown). This
TABLE II
Kinetic constants of the interaction of proOmpA or
proOmpA:SecB with SecYEG bound SecA
Ligand kon koff KD
M
1 s1 s1 M
proOmpA 2.6  0.1  105 3.6  0.1  103 14  109
proOmpA:SecB 1.9  0.3  105 2.9  0.1  103 16  109
FIG. 2. Interaction of proOmpA with the SecASecYEG com-
plex. IMVs were immobilized on the L1 chip as described and saturated
with SecA using a running buffer containing 48 nM SecA. proOmpA (100
nM; dashed line), SecB (100 nM; dotted line) or a proOmpASecB (solid
line) complex were injected at a flow rate of 20 l/min. Binding exper-
iments were done at 25 °C. The corrected data representing the specific
binding to the SecASecYEG complex are shown.
TABLE I
Kinetic constants of SecA-SecYEG interaction
IMVs kon koff koff1 koff2 KD koff/kon
M
1 s1 s1 s1 s1 M
SecYEG 2.5  0.4  106 5.2  0.4  103 2.8  0.4  102 (27%) 3.9  0.4  103 (73%) 2.0  0.2  109
SecYE 3.1  0.4  106 5.3  0.4  103 2.6  0.4  102 (26%) 4.2  0.4  103 (74%) 1.9  0.1  109
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can be explained in part by translocation of proOmpA, but this
reaction is not expected to inhibit dissociation of SecA. Only
upon a second injection with ATP, part of the complex dissoci-
ated from the membrane, whereas ADP was unable to elicit the
release (Fig. 3C). To test whether this dissociation represented
SecA that was associated previously with the SecYEG complex,
the recovery of high affinity SecA binding sites was monitored
by a new injection with SecA. For this purpose, SecA was first
injected together with the translocation ligands proOmpA,
SecB, and ATP and allowed to dissociate in the presence or
absence of ATP. Subsequently, a second injection of SecA was
passed over the sensor chip, and the binding responses were
compared with that of SecA in the absence of translocation
ligands (initial response) (Fig. 3D). When complex dissociation
was analyzed in the absence of ATP, a second SecA injection
resulted in a response of only 30% of the initial response (Fig.
3D). However, when the complex was allowed to dissociate in
the presence of ATP, a second injection of SecA resulted in a
response of 55% (Fig. 3D). The increase in SPR response cor-
responds to the amount of material that dissociated from the
membrane upon injection of ATP (Fig. 3C). This suggests that
ATP is able to release part of the complex from high affinity
SecA binding sites. ADP or the non-hydrolysable ATP analogue
AMP-PNP failed to dissociate the complex, and under those
conditions no high affinity binding sites for SecA were recov-
ered (data not shown). These results demonstrate that the
dissociation of SecA from the membrane after one or more
rounds of translocation requires the hydrolysis of ATP. An
ATP-dependent release from the membrane has previously
been proposed based on the behavior of a protease-protected
30-kDa fragment of SecA (21, 36). In these studies, formation of
the 30-kDa fragment could also be driven by AMP-PNP in the
absence of a preprotein. SPR showed that SecA dissociated
readily after it had been bound to the SecYEG complex in the
presence of AMP-PNP (Fig. 3E, dotted line). The dissociation
could, however, be blocked by a second injection with AMP-
PNP (Fig. 3E, solid line). These results show that also a non-
hydrolyzable ATP analogue can lock SecA at the membrane,
but in contrast to the complex formed in the presence of pre-
protein and ATP, the AMP-PNP-dependent complex readily
dissociates upon depletion of the nucleotide.
The ATP injection that is required for the dissociation of
FIG. 3. Binding of a SecAproOmpA complex to SecYEG. A, binding of SecA (48 nM), proOmpA (100 nM), and SecB (100 nM) to IMVs
containing overexpressed SecYEG in the presence (black line) or absence (dashed line) of ATP (1 mM). The buffer compositions during the
association and dissociation phase are indicated in the black and white bars, respectively. B, binding of SecA (48 nM) and proOmpASecB to
SecYEG IMVs under oxidizing (solid line) or reducing conditions in the presence (dashed line) or absence (dotted line) of ATP (1 mM). The buffer
compositions during the association and dissociation phase are indicated in the black and white bars, respectively. C, injection of 1 mM ATP (solid
line) or ADP (dotted line) over a complex formed in the presence of ATP (see A). D, response of a second round of SecA binding before (white bars)
or after injection of ATP (black bars) over the SecAproOmpASecB complex formed in the presence of ATP under reducing or oxidizing conditions
(see B). Binding responses were compared with the binding response of SecA in the absence of translocation ligands (initial response). E, binding
of SecA (12 nM) in the presence of 1 mM AMP-PNP. Dissociation occurred in the absence of AMP-PNP (dotted line). Alternatively, 1 mM AMP-PMP
was injected after 30 s of dissociation (black line). All binding experiments were performed at 30 °C, except for E, which was done at 25 °C. The
corrected data representing the specific binding to the SecYEG complex are shown.
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SecA could be necessary to complete the translocation of the
partially translocated preproteins. Alternatively, SecA could
dissociate from the membrane upon ATP hydrolysis irrespec-
tive of completion of translocation. To discriminate between
these possibilities, the dissociation of SecA from the oxidized
proOmpA translocation intermediate was studied. Similar to
the complex formed under reducing conditions, the oxidized
complex did not dissociate from the membrane at the end of
injection (Fig. 3B). Dissociation and regeneration of SecA bind-
ing sites could be obtained by addition of ATP (Fig. 3D), imply-
ing that completion of translocation is not required for the
release of SecA from the translocation site. To analyze the
re-association of SecA with translocation sites that are occu-
pied by partially translocated preproteins, binding of SecA to
an oxidized proOmpASecYEG complex was examined. SecA
was injected together with the translocation ligands
proOmpASecB and ATP under either oxidizing or reducing
conditions. After the end of the injection, complexes were al-
lowed to dissociate in the presence of ATP. Subsequently, a
second injection of SecA was passed over the sensor chip, and
the binding responses were compared. After preincubation un-
der oxidizing or reducing conditions, the second SecA injection
resulted in a similar SPR response of 60 RU (see Fig. 3D and
Fig. 4, left panel). The dissociation phase, however, was differ-
ent for the two conditions. When SecA was bound to the oxi-
dized proOmpASecYEG complex it remained stably associated
with the membrane (Fig. 4, left panel). Again ATP was required
for dissociation (Fig. 4, right panel), whereas AMP-PNP and
ADP were unable to release SecA.
The second round of SecA binding to the complex formed
under reducing conditions was reversible, and dissociation oc-
curred immediately after the end of the injection (Fig. 4, left
panel). In contrast to oxidized proOmpA, reduced proOmpA
does not form stable translocation intermediates. Likewise,
after reduction of the disulfide bond of oxidized proOmpA with
dithiothreitol, a second injection of SecA also resulted in re-
versible binding (data not shown). Conversion of the interme-
diate I29 to full-length translocated proOmpA can be driven by
low ATP concentrations once the disulfide bridge is reduced
(19). Taken together, these results show that SecA binds with
a very high affinity to the SecYEG complex when it contains a
partially translocated preprotein and that effective dissociation
of this preproteinSecYEG complex requires the hydrolysis of
ATP.
DISCUSSION
The SecA motor of the E. coli preprotein translocase is a
highly dynamic protein that in the cell distributes between
cytosolic and membrane-associated states (37). The interaction
of SecA with the inner membrane has been studied previously
by binding experiments using radiolabeled SecA. This demon-
strated that the SecA association with the membrane occurs
with high affinity with the SecYEG complex (34) and with low
affinity with the negatively charged lipids (12). Unfortunately,
this discontinuous binding assay provides no information about
the kinetics of the interaction and cannot easily be applied
when protein translocation conditions prevail. To directly mon-
itor the SecA interaction with SecYEG, we have analyzed this
process by SPR. This technique has been used extensively for
studies on soluble proteins, but the method has only recently
become applicable for studies on the interaction with mem-
branes. So far, these studies only concerned the interaction
between a soluble protein or peptide and a lipid bilayer. The
results presented here show that SPR can be used to obtain
detailed and quantitative information on the interaction be-
tween the peripheral SecA protein and its membrane receptor,
the SecYEG complex. The affinity for the binding of SecA to
SecYEG determined by SPR is comparable with values deter-
mined previously (30) by binding experiments with radiola-
beled SecA. In addition, SPR could be used to study the inter-
actions that occur during protein translocation.
Based on the formation of a protease-protected 30-kDa frag-
ment, the SecA reaction cycle has been proposed to involve
nucleotide-induced membrane insertion and de-insertion steps
(21). Because the 30-kDa fragment could be chased by an
excess of non-radioactive SecA, SecA was proposed to alternate
between a cytosolic and membrane-associated state during its
reaction cycle (21). However, other studies failed to demon-
strate a translocation-dependent dissociation of membrane-
bound SecA and concluded that membrane cycling is not an
essential feature for protein translocation (22). The SPR results
presented here demonstrate directly that SecA can dissociate
from the activated SecYEG complex during a translocation
cycle. In the absence of a preprotein, SecA binding to the
SecYEG complex is readily reversible. However, when SecA is
actively engaged with a preprotein trapped in the translocation
channel, SecA release strictly requires the hydrolysis of ATP.
The ATP-dependent dissociation is not related to completion of
translocation, because SecA also dissociates in an ATP-depend-
ent manner from partially translocated preproteins that re-
main trapped because of the presence of disulfide bridge. These
data confirm previous suggestions that upon ATP hydrolysis,
SecA releases the bound preprotein (19). However, in contrast
to our SPR study, this conclusion was based on an experiment
with SecA bound to lipid vesicles in the absence of the SecYEG
complex under non-translocating conditions.
The SPR observations also show resemblance to the behavior
of the SecA proteolytic 30-kDa fragment that can be chased by
an excess of non-radioactive SecA in the presence of ATP (21),
although this experiment does not demonstrate net release of
SecA from the translocation site. In the absence of a preprotein,
the 30-kDa fragment of SecA could be formed in the presence of
non-hydrolyzable ATP analogs, and formation of the 30-kDa
SecA fragment was attributed to the binding of ATP during the
translocation reaction (36). The requirements for the formation
of a stable SecASecYEG complex that was detected by SPR are
FIG. 4. SecA binding to a proOmpASecYEG complex. The trans-
location complex was formed under oxidizing (solid line) or reducing
(dashed line) conditions (see Fig. 3B), and SecA was dissociated from
the translocation complex by an injection with an ATP-containing
buffer. Left panel, rebinding of SecA after formation of a translocation
complex. Right panel, dissociation of rebound SecA from the oxidized
complex in the presence (solid line) or absence (dotted line) of ATP or
from the reduced complex in the absence of ATP (dashed line). All
binding experiments were performed at 30 °C. SecA, proOmpA, SecB,
and ATP were present at a concentration of 48 nM, 100 nM, 100 nM, and
1 mM, respectively. The corrected data representing the specific binding
to the proOmpASecYEG complex are shown.
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different. Various reports suggest that the 30-kDa fragment
formed in the presence of AMP-PNP may differ from the one
formed under translocation conditions (36, 39). The SPR exper-
iments demonstrate that SecA readily dissociated form the
SecYEG complex after injection in the presence of AMP-PNP,
unless the nucleotide was also present during the dissociation.
A SecASecYEG complex that remained stable after depletion
of nucleotides could only be formed under translocation condi-
tions or when SecA re-bound to the SecYEG complex containing
a partially translocated preprotein. This suggests that stable
membrane association of SecA under translocation conditions
is dependent on the presence of a preprotein rather than the
binding of ATP. The presence of the preproteins is, however,
not sufficient as a dissociable SecApreproteinSecYEG complex
is formed when SecA and proOmpA are injected in the absence
of ATP (Fig. 3, A and C). Apparently, stable membrane associ-
ation of SecA does not result from the binding of ATP directly
but needs to be preceded by an ATP-dependent preprotein
translocation step. A possible explanation for this phenomenon
is that SecA interacts with high affinity with the exposed
non-translocated polypeptide domains of the preprotein. This
may anchor SecA more stable to the SecYEG pore complex such
that ATP hydrolysis is needed to dissociate the SecA-preprotein
interaction (19). Alternative explanations need to be consid-
ered, as well. SecA has been proposed to be subjected to
changes in its quaternary structure during its reaction cycle
(40–42). Differences in the oligomeric state of SecA could affect
the affinity of the SecA-SecYEG interaction, but in our SPR
experiments we cannot discriminate between a monomeric and
dimeric state of SecA at the translocase. Because of the pres-
ence of a trapped translocation intermediate, the SecYEG com-
plex may exist in a different conformational state that permits
a tight interaction with SecA. Biochemical and electron micros-
copy studies have indicated that the translocation pore is
formed by an oligomeric assembly of SecYEG complexes (7). In
a three-dimensional structure reconstituted from two-dimen-
sional SecYEG crystals the SecYEG complex is dimeric and
displays a deep cavity at the dimer interface (38). Because this
cavity is closed at the periplasmic side of the membrane, the
structure was proposed to represent a “closed state” of the
translocation channel (38). The structure would convert into an
“open state” when the complex is actively involved in translo-
cation, but it is not clear whether the open state reflects a
different conformational or oligomeric state. In this respect,
electron microscopy suggests that SecYEG dimers tetramerize
upon activation of SecA by AMP-PNP or ATP and a preprotein
(7). Although the oligomeric state of the active SecYEG pore
complex remains a topic of debate, both models propose that
the protein-conducting pore needs to be activated at the initi-
ation of translocation. The ATP-dependent step that is required
for the stable membrane association of SecA could be related to
this activation of the translocation pore. In such a scenario,
SecA binds to the inactive SecYEG complex in a reversible
manner. Upon binding of a preprotein and ATP to SecYEG-
bound SecA the SecYEG complex is activated, and this event
locks SecA at the translocation site. When SecA is released
from the membrane after the hydrolysis of ATP, the trapped
translocation intermediate can stabilize the pore in the acti-
vated state. As a consequence, in a second reaction cycle SecA
can bind tightly to the SecYEG complex in the absence of ATP.
In a non-arrested reaction cycle, re-binding of SecA to the
translocation intermediate results in a translocation progress
(19, 20).
In conclusion, this study demonstrates for the first time that
SPR can be used to monitor the association and dissociation
kinetics of a peripheral protein component with its membrane
receptor embedded in its natural lipid environment. The SPR
results confirm a translocation model in which SecA alternates
between a free (cytosolic) and membrane-associated state. The
study further demonstrates that during the translocation reac-
tion, SecA is tightly bound to the activated SecYEG complex
but can be released upon the hydrolysis of ATP.
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